AT1R inhibitors have been shown to ameliorate arterial blood pressure and urinary albumin excretion in T1DM patients with diabetic nephropathy [11] as well as in hypertensive patients with T2DM [31]. This evidence concerns the gene ALB and type 2 diabetes mellitus.